Skip to content
Nonprofiteer
← ARC RESEARCH INSTITUTE

Form 990 for tax year 2023

Filed by ARC RESEARCH INSTITUTE.

Totals

Total revenue
$53,611,444
Total expenses
$64,203,698
Contributions and grants received
$52,978,731
Grants paid
$8,572,720
Program service revenue
$0
Investment income
$632,713
Other revenue
$0
Total assets, end of year
$155,698,196
Total liabilities, end of year
$93,814,180
Net assets or fund balances, end of year
$61,884,016
Program services expenses (Part IX)
$49,064,708
Management and general expenses
$15,138,990
Fundraising expenses
$0
Program service expenses (Part III)
$49,064,708

Program services were 76.4% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1f · All other contributions, gifts and grants

    $52,978,731

  • 2f · All other program service revenue

    total $0 · related or exempt $0 · unrelated business $0 · excluded $0

  • 3 · Investment income

    total $632,713 · excluded $632,713

  • 6c · Rental income or loss

    real property $0 · personal property $0

  • 7c · Gain or loss

    securities $0 · other assets $0

  • 11d · All other revenue

    total $0 · related or exempt $0 · unrelated business $0 · excluded $0

  • 11e · Other revenue, total

    $0

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $8,572,720 · program services $8,572,720

  • 5 · Compensation of officers, directors and key employees

    total $3,193,251 · program services $1,801,861 · management and general $1,391,390

  • 7 · Other salaries and wages

    total $10,792,988 · program services $6,090,178 · management and general $4,702,810

  • 8 · Pension plan contributions

    total $296,275 · program services $167,179 · management and general $129,096

  • 9 · Other employee benefits

    total $1,095,670 · program services $661,101 · management and general $434,569

  • 10 · Payroll taxes

    total $881,758 · program services $510,090 · management and general $371,668

  • 11a · Fees: management

    total $829,742 · program services $746,768 · management and general $82,974

  • 11b · Fees: legal

    total $1,055,228 · management and general $1,055,228

  • 11c · Fees: accounting

    total $67,118 · management and general $67,118

  • 11g · Fees: other

    total $3,053,825 · program services $210,464 · management and general $2,843,361 · fundraising $0

  • 12 · Advertising and promotion

    total $83,469 · program services $8,732 · management and general $74,737

  • 13 · Office expenses

    total $609,434 · program services $133,197 · management and general $476,237

  • 16 · Occupancy

    total $14,899,739 · program services $13,409,882 · management and general $1,489,857

  • 17 · Travel

    total $649,574 · program services $359,093 · management and general $290,481

  • 19 · Conferences, conventions and meetings

    total $127,727 · program services $21,918 · management and general $105,809

  • 22 · Depreciation, depletion and amortization

    total $7,814,257 · program services $7,032,831 · management and general $781,426

  • 23 · Insurance

    total $145,099 · management and general $145,099

  • 24a · Other expenses: Lab expenses

    total $6,904,314 · program services $6,903,182 · management and general $1,132

  • 24b · Other expenses: Student expenses

    total $1,209,582 · program services $1,209,582

  • 24c · Other expenses: Subscriptions

    total $1,011,248 · program services $629,566 · management and general $381,682

  • 24d · Other expenses: Health and safety expenses

    total $317,509 · program services $317,509

  • 24e · All other expenses

    total $593,171 · program services $278,855 · management and general $314,316 · fundraising $0

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $38,341,866 · end of year $4,091,658

  • 2 · Savings and temporary cash investments

    beginning of year $618,831 · end of year $618,831

  • 4 · Accounts receivable

    beginning of year $11,357 · end of year $6,564

  • 5 · Loans and receivables from officers and key people

    beginning of year $0 · end of year $0

  • 6 · Loans and receivables from disqualified persons

    beginning of year $0 · end of year $0

  • 9 · Prepaid expenses and deferred charges

    beginning of year $1,429,524 · end of year $1,232,853

  • 10a · Land, buildings and equipment: cost or other basis

    $99,499,504

  • 10b · Land, buildings and equipment: accumulated depreciation

    $8,616,377

  • 10c · Land, buildings and equipment, net

    beginning of year $47,856,273 · end of year $90,883,127

  • 12 · Investments: other securities

    beginning of year $1,000,000 · end of year $1,000,000

  • 13 · Investments: program-related

    beginning of year $0

  • 14 · Intangible assets

    beginning of year $0

  • 15 · Other assets

    beginning of year $60,857,768 · end of year $57,865,163

  • 17 · Accounts payable and accrued expenses

    beginning of year $8,439,343 · end of year $11,494,900

  • 22 · Loans and payables to officers and key people

    beginning of year $0 · end of year $0

  • 24 · Unsecured notes and loans payable

    beginning of year $0 · end of year $16,080,816

  • 25 · Other liabilities

    beginning of year $69,200,006 · end of year $66,238,464

  • 27 · Net assets without donor restrictions

    beginning of year $72,476,270 · end of year $61,884,016

Mission and programs · 2023

Mission

Our mission is to accelerate scientific progress, understand the root causes of disease, and narrow the gap between discoveries and impact on patients.

Activities or mission (Part I)

Our mission is to accelerate scientific progress and understand the root causes of complex diseases. This challenge requires researchers across many disciplines to study fundamental biological mechanisms, develop new technologies, and innovate on therapeutic concepts. By doing this, we aim to improve human health by narrowing the gap between discoveries and impact on patients.

  • Headquartered in Palo Alto, California, Arc is a nonprofit research organization founded on the belief that many important scientific programs can be enabled by new organizational models. Arc operates in partnership with Stanford University, UCSF, and UC Berkeley. Arc gives scientists no-strings-attached, multi-year funding, so that they don't have to apply for external grants, and INSTEAD CAN invest in the rapid development of experimental and computational technological tools. As individuals, Arc researchers collaborate across diverse disciplines to study complex diseases, including cancer, neurodegeneration, and immune dysfunction. As an organization, Arc strives to enable ambitious, long-term research agendas. The Gilbert lab's expertise is in synthetic biology, functional genomics and cancer biology. We build CRISPR epigenetic editing tools to turn genes on and off and to perturb gene regulatory elements. We are developing CRISPR functional genomics approaches to map individual genes or sets of genes that regulate phenotypes of interest in vitro and in vivo. We are focused on utilizing our expertise to tackle big problems in deadly human cancers such as metastasis and drug resistance. The Hsu Lab works at the intersection of synthetic biology and genomics to invent new biotechnologies for improving human health. The Konermann lab develops and applies next-generation functional genomics to understand the cellular and molecular pathways underlying the neuronal system and neurodegenerative disease, with the long-term goal of developing rationally targeted therapeutics for neurodegenerative disorders. At the Li Lab we combine chemistry, biochemistry, immunology, and physiology to uncover basic mechanisms in innate immunity and, in parallel, develop therapeutic hypotheses and lead molecules. Innate immune pathways as the first line of defense against pathogens present many exciting opportunities for scientists from many disciplines. These pathways are a rich source of novel chemistry: they involve diverse molecular patterns in pathogens, little-explored second messengers, and drugs with poorly understood mechanism. Activation of innate immunity is a proven therapeutic strategy for vaccination, viral infection, and cancer, while inhibition is a strategy for treating autoimmune diseases and neurodegeneration. To date, however, most modulators of innate immunity are broad, non-specific, and poorly characterized, such as killed bacteria, alum crystals, and steroids. The Li lab seeks to improve understanding of these pathways and facilitate the development of more precise drugs for preventing or treating specific diseases.

    Expenses $49,064,708 · Grants $8,572,720

As filed on the 2023 return.

Listed in Part VII

  • Nathaniel Friedman

    Secretary/Director

    Total calculated
    $36,000
    From this org
    $36,000
    From related orgs
    $0
    Other
    $0
    Hours/week
    1
  • Alden J Woodrow

    COO

    Total calculated
    $777,341
    From this org
    $742,239
    From related orgs
    $0
    Other
    $35,102
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $381,399
    Bonus
    $360,600
    Other
    $240
    Deferred
    $16,500
    Nontaxable benefits
    $18,602
    Filer's total
    $777,341
  • Daniel Dever PhD

    Head of Scientific Operations

    Total calculated
    $125,907
    From this org
    $117,098
    From related orgs
    $0
    Other
    $8,809
    Hours/week
    40
  • Julia M Kazaks

    General Counsel

    Total calculated
    $390,872
    From this org
    $365,174
    From related orgs
    $0
    Other
    $25,698
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $317,722
    Bonus
    $46,900
    Other
    $552
    Deferred
    $16,500
    Nontaxable benefits
    $9,198
    Filer's total
    $390,872
  • Lynn M Hendrickson

    University Relations & Academic Affairs

    Total calculated
    $352,565
    From this org
    $338,360
    From related orgs
    $0
    Other
    $14,205
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $279,320
    Bonus
    $58,800
    Other
    $240
    Deferred
    $14,205
    Nontaxable benefits
    $0
    Filer's total
    $352,565
  • Nicolle D Seuss

    Senior Operations Program Manager

    Total calculated
    $291,589
    From this org
    $270,911
    From related orgs
    $0
    Other
    $20,678
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $229,898
    Bonus
    $40,500
    Other
    $513
    Deferred
    $13,840
    Nontaxable benefits
    $6,838
    Filer's total
    $291,589
  • Patrick D Hsu PhD

    Core Investigator

    Total calculated
    $524,132
    From this org
    $504,392
    From related orgs
    $0
    Other
    $19,740
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $457,280
    Bonus
    $46,920
    Other
    $192
    Deferred
    $16,500
    Nontaxable benefits
    $3,240
    Filer's total
    $524,132
  • Rose E Harris

    Finance

    Total calculated
    $151,655
    From this org
    $151,655
    From related orgs
    $0
    Other
    $0
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $130,320
    Bonus
    $21,200
    Other
    $135
    Deferred
    $0
    Nontaxable benefits
    $0
    Filer's total
    $151,655
  • Silvana M Konermann PhD

    Executive Director

    Total calculated
    $226,686
    From this org
    $225,268
    From related orgs
    $0
    Other
    $1,418
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $204,502
    Bonus
    $20,600
    Other
    $166
    Deferred
    $0
    Nontaxable benefits
    $1,418
    Filer's total
    $226,686
  • Susan Cull

    Senior Finance

    Total calculated
    $163,576
    From this org
    $156,004
    From related orgs
    $0
    Other
    $7,572
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $149,754
    Bonus
    $6,000
    Other
    $250
    Deferred
    $7,572
    Nontaxable benefits
    $0
    Filer's total
    $163,576
  • Therese Costello

    Head of People

    Total calculated
    $152,930
    From this org
    $146,619
    From related orgs
    $0
    Other
    $6,311
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $146,095
    Bonus
    $400
    Other
    $124
    Deferred
    $5,833
    Nontaxable benefits
    $478
    Filer's total
    $152,930
  • Benjamin N Mijts

    Senior Director, Genome Engineering Technology Center

    Total calculated
    $280,219
    From this org
    $259,934
    From related orgs
    $0
    Other
    $20,285
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $252,098
    Bonus
    $7,500
    Other
    $336
    Deferred
    $12,625
    Nontaxable benefits
    $7,660
    Filer's total
    $280,219
  • Jennifer A Moss

    Senior Recruiter

    Total calculated
    $357,568
    From this org
    $341,470
    From related orgs
    $0
    Other
    $16,098
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $271,026
    Bonus
    $70,100
    Other
    $344
    Deferred
    $16,098
    Nontaxable benefits
    $0
    Filer's total
    $357,568
  • Lingyin Li

    Core Investigator

    Total calculated
    $290,224
    From this org
    $283,866
    From related orgs
    $0
    Other
    $6,358
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $236,041
    Bonus
    $47,600
    Other
    $225
    Deferred
    $2,479
    Nontaxable benefits
    $3,879
    Filer's total
    $290,224
  • Luke Gilbert

    CORE INVESTIGATOR

    Total calculated
    $294,436
    From this org
    $279,098
    From related orgs
    $0
    Other
    $15,338
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $232,502
    Bonus
    $46,400
    Other
    $196
    Deferred
    $13,920
    Nontaxable benefits
    $1,418
    Filer's total
    $294,436
  • Nianzhen Li PHD

    Senior Director, Multi-omics technology development

    Total calculated
    $278,190
    From this org
    $274,094
    From related orgs
    $0
    Other
    $4,096
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $259,150
    Bonus
    $14,600
    Other
    $344
    Deferred
    $3,918
    Nontaxable benefits
    $178
    Filer's total
    $278,190

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 1a · Tax indemnification and gross-up payments
  • 3 · Independent compensation consultant
  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee
  • 4a · Severance or change-of-control payment
  • 7 · Other non-fixed payments

Answered no

  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 8 · Paid under the initial-contract exception

The filer's explanations (Part III)

Schedule J, Part I, Line 1a Tax indemnification and gross-up payments
2 executives received tax gross-up payments. These are treated as taxable compensation to individuals.
Schedule J, Part I, Line 4a Severance or change-of-control payment
THE FOLLOWING INDIVIDUALS RECEIVED SEVERANCE PAY DURING 2023 (INCLUDED IN SCHEDULE J, PART II, COLUMN (B)(III): BENJAMIN N MIJTS - $ JENNIFER A MOSS - $ DANIEL DEVER, PHD - $
Schedule J, Part I, Line 7 Non-fixed payments
For each full year of employment with the Institute, individuals shall be eligible to earn an annual bonus of up to a percentage of their effective Base Salary ("Annual Bonus"), based half on their and half on the Institute's achievement of performance goals established in advance by the Board of Directors of the Institute ("Board") or its delegate and provided in writing, contingent on the individuals remaining actively employed with the Institute through the payment date of each Annual Bonus. The Annual Bonus will be prorated based on start date. The Annual Bonus, if any, will be earned and paid no later than two and a half months after the end of the fiscal year, at which point the Board (or its delegate) will also have determined goals for the then current fiscal year. All bonus payments shall be made less deductions and withholdings required by law or approved by the individuals. COO Bonus program: For each year of employment with the Institute, the COO shall be eligible to earn a discretionary bonus, on a semi-annual basis, in the target amount of 50% of their then effective Base Salary, based on: (a) the extent of their achievement against individual performance goals set for each semi-annual period, and (b) overall performance rating for that semi-annual period ("Individual Performance Bonus"). The goals for each bonus period will be mutually agreed upon between the COO and the Institute and provided in writing. In each semi-annual period, if the COO achieves the goals and receives a performance rating of "3 - Exemplary," they will be eligible for the target bonus amount (50% of Base Salary). If they achieve fewer than all goals or receive a performance rating of "2 - Success," they will be eligible for a partial bonus in an amount deemed appropriate for the level of performance. If they receive a performance rating of "1 - Missed Expectations," they will not be eligible for any bonus for the period. Decisions concerning performance ratings, whether they receive an Individual Performance Bonus in any semi-annual period, and the amount of any such bonus, shall be at the Institute's discretion. Each Individual Performance Bonus, if awarded, will be paid by April 30 or October 31, as applicable. Eligibility to receive any Individual Performance Bonus payment is contingent upon the COO remaining actively employed with the Institute through the scheduled payment date. All bonus payments will be made less deductions and withholdings required by law or approved by the COO.

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

Taxable family on this return

Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.

Disregarded entities

Part I: entities that legally are the filer and file no return of their own.

  • ARC MOBILITY LLC

    TRANSPORTATION · DE · income $0 · assets $0

    Directly controlled by ARC RESEARCH INSTITUTE

Provenance

Return type
form_990
Tax year
2023
Filed
13 November 2024
IRS schema version
2023v5.1
Source object
202423189349308952

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.